Literature DB >> 8882587

Functional, endogenously expressed 5-hydroxytryptamine 5-ht7 receptors in human vascular smooth muscle cells.

P Schoeffter1, C Ullmer, I Bobirnac, G Gabbiani, H Lübbert.   

Abstract

Human uterine artery smooth muscle cells in culture were shown to express constitutively both 5-ht7 receptor mRNA and 5-ht7-like receptors functionally linked to cyclic AMP formation. 5-Carboxamidotryptamine (5-CT) and 5-HT enhanced forskolin-stimulated cyclic AMP accumulation in these cells, with pEC50 values of 7.12 and 6.25, sumatriptan being very weakly active. Both methiothepin (0.1 microM) and clozapine (1 microM), but not the 5-HT4-receptor antagonist, SDZ 205-557 (10 microM) antagonized the effects of 5-CT. In reverse transcriptase-polymerase chain reaction analysis, the mRNA for 5-ht7, but not for 5-HT4 or 5-ht6 receptors was found to be strongly expressed in the same cells. These findings represent a further step toward the recognition of 5-ht7 receptors as real, functional receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882587      PMCID: PMC1909805          DOI: 10.1111/j.1476-5381.1996.tb16687.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain.

Authors:  Z P To; D W Bonhaus; R M Eglen; L B Jakeman
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

2.  5-Hydroxytryptamine 5-HT1B receptors inhibiting cyclic AMP accumulation in rat renal mesangial cells.

Authors:  P Schoeffter; J Pfeilschifter; I Bobirnac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

3.  Human arterial smooth muscle cells in culture: inverse relationship between proliferation and expression of contractile proteins.

Authors:  G Fager; G K Hansson; A M Gown; D M Larson; O Skalli; G Bondjers
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

4.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.

Authors:  J A Bard; J Zgombick; N Adham; P Vaysse; T A Branchek; R L Weinshank
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

Review 5.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

6.  Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.

Authors:  A J Sleight; C Carolo; N Petit; C Zwingelstein; A Bourson
Journal:  Mol Pharmacol       Date:  1995-01       Impact factor: 4.436

7.  Expression of serotonin receptor mRNAs in blood vessels.

Authors:  C Ullmer; K Schmuck; H O Kalkman; H Lübbert
Journal:  FEBS Lett       Date:  1995-08-21       Impact factor: 4.124

8.  Regulation of histamine- and UTP-induced increases in Ins(1,4,5)P3, Ins (1,3,4,5)P4 and Ca2+ by cyclic AMP in DDT1 MF-2 cells.

Authors:  H Sipma; M Duin; B Hoiting; A den Hertog; A Nelemans
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

  8 in total
  12 in total

1.  [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.

Authors:  D R Thomas; P J Atkinson; M Ho; S M Bromidge; P J Lovell; A J Villani; J J Hagan; D N Middlemiss; G W Price
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

3.  Functional expression of the serotonin 5-HT7 receptor in human glioblastoma cell lines.

Authors:  Cécile Mahé; Michel Bernhard; Ionel Bobirnac; Corinna Keser; Erika Loetscher; Dominik Feuerbach; Kumlesh K Dev; Philippe Schoeffter
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

4.  Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

Authors:  Ellen M Bouma; Denise P I van de Pol; Ilson D Sanders; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist.

Authors:  J J Hagan; G W Price; P Jeffrey; N J Deeks; T Stean; D Piper; M I Smith; N Upton; A D Medhurst; D N Middlemiss; G J Riley; P J Lovell; S M Bromidge; D R Thomas
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

6.  An endogenous 5-HT(7) receptor mediates pigment granule dispersion in Xenopus laevis melanophores.

Authors:  M T Teh; D Sugden
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs.

Authors:  S Jähnichen; E Glusa; H H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-12-04       Impact factor: 3.000

8.  Smooth muscle layer-dependent distribution of 5-hydroxytryptamine(7) receptor in the porcine myometrium.

Authors:  T Kitazawa; Y Yamada; H Iwano; H Yokota; A Yuasa; T Taneike
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

9.  Dietary trace amine-dependent vasoconstriction in porcine coronary artery.

Authors:  A A Herbert; E J Kidd; K J Broadley
Journal:  Br J Pharmacol       Date:  2008-07-07       Impact factor: 8.739

10.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice.

Authors:  P B Hedlund; P E Danielson; E A Thomas; K Slanina; M J Carson; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.